Breaking News

GDMC to Expand Presence in the US and APAC Markets

Singapore advanced therapy drug manufacturer secures $21mn growth capital funding to expand global genetic medicines design and manufacturing operations.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genetic Design and Manufacturing Corporation (GDMC), a design and manufacturing organization that focuses on next generation advanced genetic therapies, secured a Series A funding of $21 million, led by Celadon Partners, an Asia private equity firm. The funds will be used to accelerate novel technology and process efficiency improvements to drive greater manufacturing cost reductions for partners who aim to advance medicines through clinical trials and towards commercialization. “The proce...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters